Multi-centre parallel arm randomised controlled trial to assess the effectiveness and cost-effectiveness of a group-based cognitive behavioural approach to managing fatigue in people with multiple sclerosis

BMC Neurology

Volumn 10, Issue , 2010, Pages

  Thomas, Peter W ^a,b   Thomas, Sarah ^a   Kersten, Paula ^c   Jones, Rosemary ^d   Nock, Alison ^a   Slingsby, Vicky ^a   Green, Colin ^e   Baker, Roger ^a,b,f   Galvin, Kate ^b   Hillier, Charles ^a  

^a POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b BOURNEMOUTH UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d FRENCHAY HOSPITAL   (United Kingdom)

^e UNIVERSITY OF EXETER   (United Kingdom)

^f DORSET HEALTHCARE UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL PRACTICE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DAILY LIFE ACTIVITY; DISEASE SEVERITY; ENERGY BALANCE; FATIGUE; HUMAN; INTERMETHOD COMPARISON; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MOOD CHANGE; MULTICENTER STUDY; MULTIPLE SCLEROSIS; PATIENT SATISFACTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SELF CONCEPT; SELF REPORT; SENSITIVITY ANALYSIS; THERAPY EFFECT; TREATMENT OUTCOME; AFFECT; ECONOMICS; FOLLOW UP; HOSPITALIZATION; METHODOLOGY; MOTOR ACTIVITY; PHASE 4 CLINICAL TRIAL; PSYCHOLOGICAL ASPECT;

AFFECT; COGNITIVE THERAPY; COST-BENEFIT ANALYSIS; FATIGUE; FOLLOW-UP STUDIES; HUMANS; MOTOR ACTIVITY; MULTIPLE SCLEROSIS; QUALITY OF LIFE; SELF EFFICACY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77954841397     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-10-43     Document Type: Article

References (79)

1. Compston A, McDonald IR, Noseworthy J, Lassman H, Miller DH, Smith KJ, Wekerle H, Confavreux C. McAlpine's multiple sclerosis. 2006, Philadelphia: Churchill Livingstone Elsevier Inc, 4.
2. Neild C. What is MS?. 2008, :UK: Multiple Sclerosis Society, 3.
3. Compston A, Coles A. Multiple sclerosis. Lancet 2002, 359:1221-31. 10.1016/S0140-6736(02)08220-X, 11955556.
4. Branas P, Jordan RE, Fry-Smith A, Burls A, Hyde CJ. Treatments for fatigue in multiple sclerosis: a rapid and systematic review. Health Technol Assess 2000, 4:27.
5. Johansson S, Ytterberg C, Hillert J, Widén Holmqvist L, von Koch L. A longitudinal study of variations in and predictors of fatigue in multiple sclerosis. J Neurol Neurosurg Psychiatry 2008, 79:454-7. 10.1136/jnnp.2007.121129, 18344396.
6. Lerdal A, Gulowsen Celius E, Krupp L, Dahl A. A prospective study of patterns of fatigue in multiple sclerosis. Eur J Neurol 2007, 14:1338-43. 10.1111/j.1468-1331.2007.01974.x, 17903208.
7. MS Council for Clinical Practice Guidelines Fatigue and multiple sclerosis: evidence-based management strategies for fatigue in multiple sclerosis. 1998, Washington, DC: Paralyzed Veterans of America, MS Council for Clinical Practice Guidelines.
8. Schwid SR, Covington M, Segal BM, Goodman AD. Fatigue in multiple sclerosis: current understanding and future directions. J Rehabil Res Dev 2002, 39:211-24.
9. Racke M, Hawker K, Frohman EM. Fatigue in MS: is the picture getting simpler or more complex?. Arch Neurol 2004, 61:176-7. 10.1001/archneur.61.2.176, 14967763.
10. Bakshi R, Shaikh ZA, Miletich RS, Czarnecki D, Dmochowski J, Henschel K, Janardhan V, Dubey N, Kinkel PR. Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult Scler 2000, 6:181-5.
11. Kos D, Kerckhofs E, Nagels G, D'hooghe MB, Ilsbroukx S. Origin of fatigue in multiple sclerosis: review of the literature. Neurorehabil Neural Repair 2008, 22:91-100.
12. Costello K, Harris C. Differential diagnosis and management of fatigue in multiple sclerosis:considerations for the nurse. J Neurosci Nurs 2003, 35:139-148.
13. Monks J. Experiencing symptoms in chronic illness: fatigue in multiple sclerosis. Int Disabil Stud 1989, 11:78-83.
14. Edgley K, Sullivan M, Dehoux E. A survey of multiple sclerosis. ii: Determinants of employment status. Can J Rehabil 1991, 4:127-32.
15. Grima DT, Torrance GW, Francis G, Rice G, Rosner AJ, Lafortune L. Cost and health related quality of life consequences of multiple sclerosis. Mult Scler 2000, 6:91-98.
16. Burgess M. Multiple sclerosis: theory and practice for nurses. 2002, London: Whurr.
17. White CP, White MB, Russell CS. Invisible and visible symptoms of multiple sclerosis: which are more predictive of health distress?. J Neurosci Nurs 2008, 40:85-95. 10.1097/01376517-200804000-00007, 18481738.
18. Ritvo PG, Fisk JD, Archibald CJ, Murray TJ, Field C. Psychosocial and neurological predictors of mental health in multiple sclerosis. J Clin Epidemiol 1996, 49:467-72. 10.1016/0895-4356(95)00027-5, 8621999.
19. Schwartz CE, Coulthard-Morris L, Zeng Q. Psychosocial correlates of fatigue in multiple sclerosis. Arch Phys Med Rehabil 1996, 77:165-70. 10.1016/S0003-9993(96)90162-8, 8607741.
20. Vercoulen JHMM, Swanink CMA, Galama JMD, Fennis JFM, Jongen PJH, Hommes OR, van der Meer JWM, Bleijenberg G. The persistence of fatigue in chronic fatigue syndrome and multiple sclerosis: development of a model. J Psychosom Res 1998, 45:507-17. 10.1016/S0022-3999(98)00023-3, 9859853.
21. Pucci E, Brañas Tato P, D'Amico R, Giuliani G, Solari A, Taus C. Amantadine for fatigue in multiple sclerosis. Cochrane Database of Systematic Reviews 2007, (1). Art. No.: CD002818. DOI: 10.1002/14651858.CD002818.pub2.
22. Tejani AM, Wasdell M, Spiwak R, Rowell G, Nathwani S. Carnitine for fatigue in multiple sclerosis. Cochrane Database of Systematic Reviews 2010, (2). Art. No.: CD007280. DOI: 10.1002/14651858.CD007280.pub2.
23. Stapleton T, Mulholland L. Assessment of a fatigue management programme for people with multiple sclerosis. Int J Ther Rehabil 2004, 11:547-53.
24. Bowcher H, May M. Occupational therapy for the management of fatigue in multiple sclerosis. Br J Occup Ther 1998, 16:488-92.
25. Mathiowetz V, Matuska KM, Murphy ME. Efficacy of an energy conservation course for persons with multiple sclerosis. Arch Phys Med Rehabil 2001, 82:449-56. 10.1053/apmr.2001.22192, 11295003.
26. Vanage SM, Gilbertson KK, Mathiowetz V. Effects of an energy conservation course on fatigue impact for persons with progressive multiple sclerosis. Am J Occup Ther 2003, 57:315-23.
27. Steultjens EMJ, Dekker J, Bouter LM, Cardol M, Van de Nes JCM, Van den Ende CHM. Occupational therapy for multiple sclerosis. Cochrane Database of Systematic Reviews (3). Art. No.: CD003608; 2003. doi:10.1002/14651858.CD003608.
28. Ward N, Winters S. Results of a fatigue management programme in multiple sclerosis. Br J Nurs 2003, 12:1075-80.
29. Harrison S. Fatigue management for people with multiple sclerosis. 2007, London: College of Occupational Therapists, 2.
30. Mathiowetz VG, Finlayson ML, Matuska KM, Chen HY, Luo P. Randomized controlled trial of an energy conservation course for persons with multiple sclerosis. Mult Scler 2005, 11:592-601. 10.1191/1352458505ms1198oa, 16193899.
31. Packer TL, Brink N, Sauriol A. Managing fatigue: a six-week course for energy conservation. 1995, Tucson: Therapy Skill Builders.
32. Mathiowetz VG, Matuska KM, Finlayson ML, Luo P, Chen HY. One-year follow-up to a randomized controlled trial of an energy conservation course for persons with multiple sclerosis. Int J Rehabil Res 2007, 30:305-13. 10.1097/MRR.0b013e3282f14434, 17975450.
33. Sauter C, Zebenholzer K, Hisakawa J, Zeitlhofer J, Vass K. A longitudinal study on effects of a six-week course for energy conservation for multiple sclerosis patients. Mult Scler 2008, 14:500-5. 10.1177/1352458507084649, 18208883.
34. Kos D, Duportail M, D'hooghe MB, Nagels G, Kerckhofs E. Multi-disciplinary fatigue management programme in multiple sclerosis: a randomised clinical trial. Mult Scler 2007, 13:996-1003. 10.1177/1352458507078392, 17623738.
35. van Kessel K, Moss-Morris R. Understanding multiple sclerosis fatigue: a synthesis of biological and psychological factors. J Psychosom Res 2006, 61:583-5. 10.1016/j.jpsychores.2006.03.006, 17084134.
36. Lee D, Newell R, Ziegler L, Topping A. Treatment of fatigue in multiple sclerosis: a systematic review of the literature. Int J Nurs Pract 2008, 14:81-93. 10.1111/j.1440-172X.2008.00670.x, 18315820.
37. Whiting P, Bagnall AM, Sowden AJ, Cornell JE, Mulrow CD, Ramirez G. Interventions for the treatment and management of chronic fatigue syndrome: a systematic review. J Amer Med Assoc 2001, 286:1360-8.
38. Price JR, Couper J. Cognitive behaviour therapy for chronic fatigue syndrome in adults. Cochrane Database of Systematic Reviews (4). Art. No.:CD001027; 1998. doi:10.1002/14651858.CD001027.
39. Thomas PW, Thomas S, Hillier C, Galvin K, Baker R. Psychological interventions for multiple sclerosis. Cochrane Database of Systematic Reviews (1). Art. No.: CD004431; 2006. doi:10.1002/14651858.CD004431.pub2.
40. van Kessel K, Moss-Morris R, Willoughby E, Chalder T, Johnson MH, Robinson E. A Randomized controlled trial of cognitive behavior therapy for multiple sclerosis fatigue. Psychosom Med 2008, 70:205-13. 10.1097/PSY.0b013e3181643065, 18256342.
41. Sinclair VG, Scroggie J. Effects of a cognitive-behavioral program for women with multiple sclerosis. J Neurosci Nurs 2005, 37:249-57. 10.1097/01376517-200510000-00004, 16379131.
42. Visschedijk MAJ, Collette EH, Polan CH, Pfennings LEMA, Van der Ploeg HM. Development of a cognitive behavioral group intervention programme for patients with multiple sclerosis: an exploratory study. Psychol Rep 2004, 95:735-46. 10.2466/PR0.95.7.735-746, 15666900.
43. Tesar N, Baumhackl U, Kopp M, Günther V. Effects of psychological group therapy in patients with multiple sclerosis. Acta Neurol Scand 2003, 107:394-9. 10.1034/j.1600-0404.2003.00077.x, 12757470.
44. Sutherland JK, Cowan P. Using special interest sessions to design and implement a fatigue management group for people with multiple sclerosis. Psychol Bull 2005, 29:388-91.
45. Thomas S, Thomas PW, Nock A, Slingsby V, Glavin K, Baker R, Moffat N, Hillier C. Development and preliminary evaluation of a cognitive behavioural approach to fatigue management in people with multiple sclerosis. Patient Educ Couns 2009, doi:10.1016/j.pec2009.07.001.
46. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. Brit Med J 2008, 337:a1655. 10.1136/bmj.a1655, 2769032, 18824488.
47. Jacob C. Statistical Power Analysis for the Behavioral Sciences. 1988, Hillsdale: NJ Lawrence Erlbaum Associates, 2.
48. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW. New diagnostic criteria for multiple sclerosis: guidelines for research proposals. Ann Neurol 1983, 13:227-31. 10.1002/ana.410130302, 6847134.
49. McDonald WI, Compston A, Edan G, Goodkin D, Hartung H-P, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, Van Den Noort S, Weinshenker BY, Wolinsky JS. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001, 50:121-7. 10.1002/ana.1032, 11456302.
50. Polman CH, Reingold SC, Edan G, Filippi M, Hartung H-P, Kappos L, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2005 revisions to the ''McDonald Criteria''. Ann Neurol 2005, 58:840-6. 10.1002/ana.20703, 16283615.
51. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989, 10:1121-3.
52. Orme M, Kerrigan J, Tyas D, Russell N, Nixon R. The effect of disease, disability and relapses on the utility of people with multiple sclerosis in the UK. Value Health 2007, 10:54-60. 10.1111/j.1524-4733.2006.00144.x, 17261116.
53. National Association of Neurological Occupational Therapists Occupational Therapy Fatigue Management Pack. 2004, London: National Association of Neurological Occupational Therapists, National Association of Neurological Occupational Therapists.
54. MS Essentials 14. 2009, Fatigue. MS Society., http://www.mssociety.org.uk/support_and_services/free_publications/ms_essentials_14.html
55. Schwartz JE, Jandorf L, Krupp L. The measurement of fatigue: a new instrument. J Psychosom Res 1993, 37:753-62. 10.1016/0022-3999(93)90104-N, 8229906.
56. Hobart J, Lamping D, Riazi A. The multiple sclerosis impact scale (MSIS-29): a new patient-based outcome measure. Brain 2001, 124:962-73. 10.1093/brain/124.5.962, 11335698.
57. Hobart JC, Riazi A, Lamping D, Fitzpatrick R, Thompson A. Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome. Health Technol Assess 2004, 8:1-60.
58. Schwartz CE, Coulthard-Morris L, Zeng Q, Retzlaff P. Measuring self-efficacy in people with multiple sclerosis: a validation study. Arch Phys Med Rehabil 1996, 77:394-8. 10.1016/S0003-9993(96)90091-X, 8607766.
59. Ware JE, Sherbourne CD. The MOS 36-item Short-Form health survey (SF-36):I. Conceptual framework and item selection. Med Care 1992, 30:473-83. 10.1097/00005650-199206000-00002, 1593914.
60. Freeman JA, Hobart JC, Langdon DW, Thompson AJ. Clinical appropriateness:a key factor in outcome measure selection: the 36 item short form health survey in multiple sclerosis. J Neurol Neurosurg Psychiatry 1999, 68:150-156.
61. The EuroQol Group EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990, 16:199-208. 10.1016/0168-8510(90)90421-9, 10109801, The EuroQol Group.
62. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Neurol Scand 1983, 67:361-70.
63. Hann D, Jacobsen P, Azzarello L, Martin SC, Curran SL, Fields KK, Greenberg H, Lyman G. Measurement of fatigue in cancer patients: Development and validation of the Fatigue Symptom Inventory. Qual Life Res 1998, 7:301-310. 10.1023/A:1008842517972, 9610214.
64. Hann D, Denniston M, Baker F. Measurement of fatigue in cancer patients: Further: validation of the Fatigue Symptom Inventory. Qual Life Res 2000, 9:847-54. 10.1023/A:1008900413113, 11297027.
65. The PDMed Trial Website. , http://www.pdmed.bham.ac.uk/investigators/PD_MED_Protocol_Version_7.1.pdf
66. Mallik PS, Finlayson M, Mathiowetz V, Fogg L. Psychometric evaluation of the energy conservation strategies survey. Clin Rehabil 2005, 19:538-543. 10.1191/0269215505cr789oa, 16119410.
67. Strauss A, Corbin J. Basics of qualitative research: techniques and procedures for developing grounded theory. 1998, Thousand Oaks, CA: Sage, 2.
68. Galvin K. Navigating a qualitative course in programme evaluation. Qualitative Research in Health Care 2005, Maidenhead: Open University Press, Holloway, I.
69. Ryan CG, Grant PM, Tigbe WW, Granat MH. The validity and reliability of a novel activity monitor as a measure of walking. Br J Sports Med 2006, 40:779-784. 10.1136/bjsm.2006.027276, 2564393, 16825270., http://www.paltechnologies.com
70. Beck A. Cognitive therapy: a thirty years retrospective. Am Psychol 1991, 466:368-75.
71. Bandura A. Social learning theory. 1971, New York: General Learning Press.
72. Kanfer FHGaelick-Buys L. Self-management methods. Helping people change: a textbook of methods 1991, 305-360. NY: Pergamon Press, Kanfer FH, Goldstein AP, 4.
73. Bandura A. Self-efficacy: toward a unifying theory of behavioural change. Psychol Rev 1977, 84:191-215. 10.1037/0033-295X.84.2.191, 847061.
74. Bauer DJ, Sterba SK, Hallford DD. Evaluating group based interventions when control participants are ungrouped. Multivar Behav Res 2008, 43:210-236.
75. Lane P. Handling drop-out in longitudinal clinical trials: a comparison of the LOCF and MMRM approaches. Pharm Stat 2008, 7:93-106. 10.1002/pst.267, 17351897.
76. Schulz KF, Altman DG, Moher D, . CONSORT Group CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Ann Int Med 2010, 152. Epub 24 March, CONSORT Group.
77. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG, . CONSORT Group CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 2010, 340:c869. 10.1136/bmj.c869, 2844943, 20332511, CONSORT Group.
78. Kobelt G, Lindgren P, Parkin D, et al. Costs and quality of life in multiple sclerosis. A cross sectional observational study in the United Kingdom. EFI. 2000, Stockholm School of Economics, Stockholm, Sweden, Research Report 398.
79. Phillips Z, Ginnelly L, Sculpher M, Claxton K, Golder S, Riemsma R, et al. Review of guidelines for good practice in decision-analytic modelling in health technology assessment. Health Technol Assess 2004, 8:1-172.